Home/Pipeline/Generic Biologics Pipeline

Generic Biologics Pipeline

Oncology, Immunology

DevelopmentActiveN/A

Key Facts

Indication

Oncology, Immunology

Phase

Development

Status

Active

Company

Gland Pharma

About Gland Pharma

Gland Pharma's mission is to be a leading global provider of high-quality, affordable injectable medicines. The company has achieved this through a combination of deep expertise in complex sterile manufacturing, strategic partnerships like the one with Fosun Pharma, and a successful IPO in 2020. Its core strategy focuses on expanding its CDMO business, leveraging its R&D for differentiated formulations, and penetrating new regulated and emerging markets to drive sustainable growth.

View full company profile

Therapeutic Areas

Anti-infectives Cardiology Critical Care Oncology Nephrology Anesthesia

Other Oncology, Immunology Drugs

Drug	Company	Phase	Status
Biosimilars Portfolio	Lupin	Various	Development
Internal Antibody Discovery Programs	Biocytogen	Pre-clinical	Active
Biosimilar Development Programs	Torrent Pharmaceuticals	Development/Clinical Trials	Active
Biosimilars Pipeline	Alkem Laboratories	Development / Clinical Trials	Active
CDMO: Complex Small Molecules	EuroAPI	Preclinical to Phase III	Development & Manufacturing